2025
Association of maternal nocturnal heart rate and adverse pregnancy outcomes
Fisher S, Huang X, Khan S, Grimaldi D, Zee P, Greenland P, Grobman W, Silver R, Facco F, Redline S, Basner R, Louis J, Pien G, Sherman‐Brown A, Schubert F, Parry S, Reddy U, Yee L, Study F. Association of maternal nocturnal heart rate and adverse pregnancy outcomes. Pregnancy 2025, 1 DOI: 10.1002/pmf2.70015.Peer-Reviewed Original ResearchSmall-for-gestational ageHypertensive disorders of pregnancyDisorders of pregnancyAdverse pregnancy outcomesNocturnal heart rateOdds of gestational diabetesGestational diabetesPregnancy outcomesAssociated with higher oddsHypertensive disordersFollow-upHeart rateHigher oddsMarkers of cardiometabolic disease riskOdds of small-for-gestational ageHome sleep studiesMultivariate logistic regression modelCardiometabolic disease riskDecreased parasympathetic activityPreterm birthLogistic regression modelsNonpregnant adultsSleep studiesProspective cohortLate pregnancy
2024
Obstetric Complications and Birth Outcomes After Antenatal Coronavirus Disease 2019 (COVID-19) Vaccination
Vesco K, Denoble A, Lipkind H, Kharbanda E, DeSilva M, Daley M, Getahun D, Zerbo O, Naleway A, Jackson L, Williams J, Boyce T, Fuller C, Weintraub E, Vazquez-Benitez G. Obstetric Complications and Birth Outcomes After Antenatal Coronavirus Disease 2019 (COVID-19) Vaccination. Obstetrics And Gynecology 2024, 143: 794-802. PMID: 38626447, PMCID: PMC11090513, DOI: 10.1097/aog.0000000000005583.Peer-Reviewed Original ResearchConceptsSmall-for-gestational ageMessenger RNA COVID-19 vaccineGestational diabetes mellitusRisk of adverse pregnancy outcomesAdverse pregnancy outcomesPreterm birthGestational hypertensionAdjusted hazard ratiosCOVID-19 vaccine dosesPregnancy outcomesCOVID-19 vaccineAssociated with small-for-gestational ageIncreased risk of adverse pregnancy outcomesVaccine doseRisk of preterm birthMessenger RNARetrospective cohort study of individualsMRNA COVID-19 vaccineWeeks of gestationRetrospective cohort studyHistory of COVID-19Cohort study of individualsVaccine Safety DatalinkSingleton pregnanciesUnexposed pregnancies
2023
Prenatal per- and polyfluoroalkyl substances (PFAS) exposure in relation to preterm birth subtypes and size-for-gestational age in the LIFECODES cohort 2006–2008
Siwakoti R, Cathey A, Ferguson K, Hao W, Cantonwine D, Mukherjee B, McElrath T, Meeker J. Prenatal per- and polyfluoroalkyl substances (PFAS) exposure in relation to preterm birth subtypes and size-for-gestational age in the LIFECODES cohort 2006–2008. Environmental Research 2023, 237: 116967. PMID: 37634691, PMCID: PMC10913455, DOI: 10.1016/j.envres.2023.116967.Peer-Reviewed Original ResearchConceptsLarge-for-gestational agePreterm birth subtypesBayesian kernel machine regressionSize-for-gestational ageSmall-for-gestational agePreterm birthFetal sexPregnancy outcomesSex-specific estimatesIncreased risk of adverse pregnancy outcomesInterquartile range increaseRisk of adverse pregnancy outcomesBayesian kernel machine regression analysisEarly pregnancy samplesAdverse pregnancy outcomesCase-control studyPrenatal PFAS exposureAssociations of polyfluoroalkyl substancesBW z-scoreEffects of polyfluoroalkyl substancesKernel machine regressionEffect modificationEffects of prenatal exposureRange increaseStratified analysis
2015
OP14.09: Prediction of small‐for‐gestational age (SGA) newborn from ultrasound biometry and maternal characteristics
Gray L, Mongelli M, Thornburg L, Mack L, Glantz C, Pressman E, Ozcan T. OP14.09: Prediction of small‐for‐gestational age (SGA) newborn from ultrasound biometry and maternal characteristics. Ultrasound In Obstetrics And Gynecology 2015, 46: 96-96. DOI: 10.1002/uog.15235.Peer-Reviewed Original ResearchSmall-for-gestational agePrediction of small-for-gestational ageUltrasound biometryMaternal characteristics
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply